India's medicinal plant ecosystem is creating opportunities across cultivation, processing, exports and value-added herbal products.
For farmers, this can mean exploring crops beyond conventional agriculture. For entrepreneurs, the opportunity can extend further into aggregation, processing, branding and exports.
But the interesting part is not just growing medicinal plants.
It is what happens after the plant leaves the farm.
Which Medicinal Plants Have Export Demand?
APEDA's analysis of India's medicinal plant product exports shows that several products recorded significant growth between FY2020 and FY2024.
Some examples include:
- Ashwagandha: 498 MT to 917 MT
- Tulsi: 133 MT to 214 MT
- Moringa: 129 MT to 195 MT
- Amla: 31 MT to 57 MT
- Triphala: 46 MT to 54 MT
Psyllium was the largest product shown in the report's medicinal plant product export category, reaching around 1,787 MT in FY2024.
Ashwagandha is particularly interesting. APEDA's analysis shows its exports growing at approximately 17% CAGR between FY2020 and FY2024. The report also identifies demand for higher-value products such as Ashwagandha extracts, Tulsi extracts and powders, Moringa capsules, Triphala capsules and extracts, and Amla extracts.
This points to an important business opportunity:
The market is not limited to raw medicinal plants.
Why Processing Can Create More Value
Consider the value chain:
Medicinal plant → Drying → Powder → Extract → Finished herbal product
A farmer may participate primarily in cultivation.
But other businesses can participate in:
- Aggregation
- Cleaning and drying
- Grading
- Powdering
- Extraction
- Packaging
- Branding
- Exporting
Processed products can have higher value, but that does not mean they are automatically more profitable. Processing requires investment, quality control, suitable technology, packaging, compliance and market access.
The opportunity is therefore about finding the right place in the value chain.
From Farm to Herbal Product
A medicinal plant business can involve several stages.
1. Cultivation
Farmers can cultivate suitable medicinal plants based on their climate, soil, cultivation requirements and market demand.
2. Aggregation
Businesses can collect raw material from multiple growers and create a more consistent supply for processors or herbal companies.
3. Primary Processing
Cleaning, drying, grading and proper storage can improve the usability and quality of the raw material.
4. Further Processing
Depending on the plant and intended market, businesses can explore powders, extracts and other processed ingredients.
5. Finished Products
The value chain can extend to consumer-facing herbal products, subject to applicable product-specific regulatory requirements.
This creates opportunities for businesses at multiple levels rather than only for farmers.
Government Support for the Sector
The National Medicinal Plants Board (NMPB) under the Ministry of AYUSH provides the institutional framework for medicinal plants.
Its Central Sector Scheme covers areas including:
- Conservation
- Cultivation
- Research and development
- Capacity building
- Quality assurance
- Good Agriculture and Collection Practices
- Development of agro-techniques
- Supply-chain development
The Central Sector Scheme guidelines covered the period 2021–22 to 2025–26. They addressed production, post-harvest technologies, certification, value addition and marketing infrastructure. That period has ended; check NMPB for current schemes, eligibility and application windows before planning around support.
The framework therefore goes beyond cultivation and also addresses quality, research, post-harvest management and market development.
The Role of e-Charak
One of the most useful government platforms for this sector is e-Charak, developed by NMPB, Ministry of AYUSH.
The current platform provides:
- Buy and sell listings
- Buyer-demand listings
- Market-price information
- Product search
- Stakeholder information
- Agro-techniques and knowledge resources
Its market-price section provides fortnightly market-price data across different markets, while its average-price section provides average prices for the previous six months.
This makes e-Charak useful for someone exploring the sector because it provides a way to understand market information and connect with potential buyers or sellers.
Where Is the Business Opportunity?
The opportunity can exist at different points in the value chain.
For farmers: cultivation of suitable medicinal plants with reliable market linkages.
For aggregators: collecting material from multiple growers and supplying processors or herbal companies.
For processors: drying, grading, powdering or other suitable processing.
For herbal businesses: developing and marketing compliant finished products.
For exporters: connecting Indian medicinal plant products with international markets.
This means the question does not always have to be:
"Which medicinal plant should I grow?"
It can also be:
"Where is the gap in the value chain?"
Challenges to Consider
Medicinal plants are not automatically high-return crops.
Before investing, businesses should consider:
Market Linkage
Identify potential buyers before committing to large-scale cultivation.
Quality
Buyers may have specific requirements relating to purity, quality and documentation.
Processing
Drying, storage, grading and further processing can significantly affect product quality and economics.
Regulatory Compliance
Requirements vary depending on whether the business is dealing with raw plant material, an ingredient, a food product, an AYUSH medicine or another finished product.
Export Requirements
Exporters need to understand product classification, destination-country requirements, documentation and applicable certifications.
Crop Suitability
A plant with strong market demand is not necessarily suitable for every location. Climate, soil, cultivation requirements and local economics all matter.
Is Medicinal Plant Cultivation a Good Business Opportunity?
It can be, but the stronger opportunity may come from looking at the entire value chain rather than cultivation alone.
APEDA's analysis shows export growth in several medicinal plant products, while also highlighting demand for higher-value products such as extracts and capsules.
That creates several possible business models:
Cultivation → Aggregation → Processing → Value Addition → Domestic Market / Export
For farmers, the opportunity may be in selecting the right crop and securing market linkages.
For entrepreneurs, it may be in processing, aggregation, quality management, branding or exports.
The key is to identify where you can create the most value.
Frequently Asked Questions
Which medicinal plants have export demand from India?
APEDA's analysis identifies products such as Psyllium, Ashwagandha, Tulsi, Moringa, Amla and Triphala among India's medicinal plant product exports. Export volumes vary by product and year.
Is Ashwagandha a growing export product?
Yes. APEDA's FY2020–FY2024 analysis shows Ashwagandha export volume increasing from 498 MT to 917 MT, equivalent to approximately 17% CAGR over the period.
Can medicinal plants be processed into higher-value products?
Yes. Depending on the plant and applicable requirements, medicinal plant material can be processed into products such as powders, extracts and other formulations. APEDA's analysis identifies demand for several such value-added forms.
Is there government support for medicinal plants?
NMPB's Central Sector Scheme covers areas such as conservation, cultivation, research, quality assurance, training, post-harvest management and supply-chain development. Specific support depends on the applicable scheme component and guidelines.
What is e-Charak?
e-Charak is an NMPB, Ministry of AYUSH platform that provides medicinal plant market information, buy and sell listings, buyer demand, market prices, stakeholder information and knowledge resources.
What should a farmer check before starting medicinal plant cultivation?
The farmer should evaluate agro-climatic suitability, cultivation requirements, expected yield, buyer availability, price risk, post-harvest requirements and applicable quality or regulatory requirements.
Final Takeaway
India's medicinal plant opportunity is bigger than cultivation alone.
The sector connects farmers, collectors, processors, herbal businesses and exporters.
Export data shows that several medicinal plant products have recorded strong growth, while demand is also developing for higher-value processed forms.
For a farmer or entrepreneur, the better question may not be:
"Which medicinal plant can I grow?"
It may be:
"Where can I create value between the farm and the final customer?"
That is where the bigger business opportunity may lie.